The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.e

Autoimmunity-Autoimmune conditions (+ANA, +anti-ds-DNA, +ANCAs, other auto-Abs)

Publications

Magno Pereira V, Andrade C, Figueira R, Faria G, Jasmins L

Infliximab-Induced Lupus: A Case Report.

GE Portuguese journal of gastroenterology 2017 Mar;24;84-88 — 2017 Mar — 84-88

Yee AM, Pochapin MB

Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy.

Annals of internal medicine 2001 Jul 03;135;27-31 — 2001 Jul 03 — 27-31